GSK unveils £1.6 billion deal to buy Canadian medicine maker Bellus Health and its blockbuster cough drug
The deal is the biggest since the old GlaxoSmithKline split in two by separating its consumer products arm
The deal is the biggest since the old GlaxoSmithKline split in two by separating its consumer products arm